Swiss Re Valuation

Is SREN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SREN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 391.49
Fair Value
65.2% undervalued intrinsic discount
15
Number of Analysts

Below Fair Value: SREN (CHF136.4) is trading below our estimate of fair value (CHF391.49)

Significantly Below Fair Value: SREN is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SREN?

Key metric: As SREN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SREN. This is calculated by dividing SREN's market cap by their current earnings.
What is SREN's PE Ratio?
PE Ratio14.7x
EarningsUS$3.35b
Market CapUS$49.68b

Price to Earnings Ratio vs Peers

How does SREN's PE Ratio compare to its peers?

The above table shows the PE ratio for SREN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.5x
ZURN Zurich Insurance Group
16.9x5.61%CHF 80.2b
SLHN Swiss Life Holding
18.8x1.53%CHF 23.0b
HELN Helvetia Holding
20.6x7.16%CHF 9.9b
BALN Baloise Holding
21.9x6.28%CHF 8.6b
SREN Swiss Re
14.7x9.84%CHF 40.4b

Price-To-Earnings vs Peers: SREN is good value based on its Price-To-Earnings Ratio (14.7x) compared to the peer average (19.5x).


Price to Earnings Ratio vs Industry

How does SREN's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
SREN 14.7xIndustry Avg. 14.4xNo. of Companies14PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SREN is expensive based on its Price-To-Earnings Ratio (14.7x) compared to the European Insurance industry average (14.4x).


Price to Earnings Ratio vs Fair Ratio

What is SREN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SREN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.7x
Fair PE Ratio21.7x

Price-To-Earnings vs Fair Ratio: SREN is good value based on its Price-To-Earnings Ratio (14.7x) compared to the estimated Fair Price-To-Earnings Ratio (21.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SREN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 136.40
CHF 140.60
+3.08%
13.32%CHF 168.97CHF 96.27n/a15
Jun ’26CHF 145.25
CHF 142.80
-1.68%
13.01%CHF 170.80CHF 97.31n/a15
May ’26CHF 147.75
CHF 140.89
-4.64%
12.38%CHF 172.22CHF 91.33n/a15
Apr ’26CHF 152.10
CHF 143.23
-5.83%
11.77%CHF 170.08CHF 97.31n/a16
Mar ’26CHF 144.30
CHF 140.87
-2.38%
11.23%CHF 165.20CHF 99.40n/a16
Feb ’26CHF 139.40
CHF 140.97
+1.13%
10.50%CHF 163.08CHF 100.93n/a16
Jan ’26CHF 131.20
CHF 139.20
+6.10%
10.65%CHF 162.31CHF 100.45n/a16
Dec ’25CHF 130.15
CHF 129.54
-0.47%
12.58%CHF 158.66CHF 97.89n/a16
Nov ’25CHF 111.90
CHF 119.97
+7.21%
13.48%CHF 140.95CHF 85.73n/a16
Oct ’25CHF 115.35
CHF 116.45
+0.96%
14.57%CHF 139.75CHF 81.29n/a16
Sep ’25CHF 115.70
CHF 115.16
-0.47%
14.68%CHF 140.41CHF 81.67n/a15
Aug ’25CHF 108.45
CHF 113.62
+4.77%
13.05%CHF 133.28CHF 83.92n/a15
Jul ’25CHF 112.40
CHF 115.24
+2.53%
12.94%CHF 135.61CHF 83.55n/a15
Jun ’25CHF 114.70
CHF 112.86
-1.60%
13.03%CHF 133.41CHF 83.92CHF 145.2515
May ’25CHF 99.82
CHF 111.89
+12.09%
13.05%CHF 135.71CHF 85.41CHF 147.7515
Apr ’25CHF 115.95
CHF 111.07
-4.21%
12.81%CHF 133.16CHF 88.34CHF 152.1015
Mar ’25CHF 106.30
CHF 107.72
+1.34%
12.40%CHF 130.41CHF 86.52CHF 144.3016
Feb ’25CHF 97.76
CHF 104.00
+6.38%
11.37%CHF 124.18CHF 84.02CHF 139.4016
Jan ’25CHF 94.56
CHF 100.26
+6.03%
11.27%CHF 121.77CHF 80.54CHF 131.2016
Dec ’24CHF 98.34
CHF 102.05
+3.77%
12.30%CHF 125.86CHF 82.24CHF 130.1516
Nov ’24CHF 100.95
CHF 100.35
-0.59%
14.33%CHF 130.19CHF 78.11CHF 111.9016
Oct ’24CHF 94.32
CHF 99.63
+5.63%
13.83%CHF 131.28CHF 78.76CHF 115.3516
Sep ’24CHF 85.64
CHF 98.01
+14.44%
15.95%CHF 142.29CHF 76.23CHF 115.7016
Aug ’24CHF 90.90
CHF 96.10
+5.72%
12.59%CHF 117.81CHF 74.03CHF 108.4516
Jul ’24CHF 90.04
CHF 97.20
+7.95%
12.66%CHF 120.46CHF 75.70CHF 112.4017
Jun ’24CHF 92.78
CHF 97.24
+4.81%
12.96%CHF 121.96CHF 76.64CHF 114.7018
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
CHF 140.60
Fair Value
3.0% undervalued intrinsic discount
15
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/13 18:35
End of Day Share Price 2025/06/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Swiss Re AG is covered by 47 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dieter HeinAlphaValue
Markus MayerBaader Helvea Equity Research
Christian ArnoldBank Vontobel AG